logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10952982 B1

PDFFull Text
Date of Patent:
Mar. 23, 2021

Filed:

May. 25, 2016

Benefits of supplementation with n-acetylcysteine and glycine to improve glutathione levels

Applicants:

Nestec S.a., Vevey, CH;

Baylor College of Medicine, Houston, TX (US);

Inventors:

Stephen Kirnon, San Ramon, CA (US);

Eric Freedland, Marblehead, MA (US);

Rajagopal V. Sekhar, Missouri City, TX (US);

Assignees:

Societe des Produits Nestle S.A., Vevey, CH;

Baylor College of Medicine, Houston, TX (US);

Attorney:

K&L Gates LLP

Primary Examiner:

Jeffrey E Russel

Int. Cl.
CPC ...
A61K 31/198 (2006.01); A61K 38/05 (2006.01); A61K 31/167 (2006.01); A61K 31/223 (2006.01); A61K 31/341 (2006.01); A61K 38/21 (2006.01); A61K 31/683 (2006.01); A61K 31/27 (2006.01); A61K 45/06 (2006.01); A61K 31/381 (2006.01); A61K 31/205 (2006.01); A23K 20/142 (2016.01); A23K 50/50 (2016.01); A61P 21/00 (2006.01); A61P 39/00 (2006.01); A61P 31/18 (2006.01); A61P 29/00 (2006.01); A61K 38/02 (2006.01);
U.S. Cl.
CPC ...
A61K 31/198 (2013.01); A23K 20/142 (2016.05); A23K 50/50 (2016.05); A61K 31/167 (2013.01); A61K 31/205 (2013.01); A61K 31/223 (2013.01); A61K 31/27 (2013.01); A61K 31/341 (2013.01); A61K 31/381 (2013.01); A61K 31/683 (2013.01); A61K 38/02 (2013.01); A61K 38/05 (2013.01); A61K 38/21 (2013.01); A61K 45/06 (2013.01); A61P 21/00 (2018.01); A61P 29/00 (2018.01); A61P 31/18 (2018.01); A61P 39/00 (2018.01);
Abstract

The present invention concerns compositions and methods related to utilizing glycine and N-acetylcysteine for a variety of medical conditions (e.g., muscle loss such as sarcopenia, HIV infection and others, organ damage such as those from diabetes and insulin resistance and diabetic nephropathy, cardiac function and failure such as preventing or improving heart failure, fatty liver, cancer prevention, and others) related to reduced levels of glycine, N-acetylcysteine, and/or glutathione.

Find Patent Forward Citations

Loading…